Vigamox 5 mg/ml øjendråber, opløsning Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

vigamox 5 mg/ml øjendråber, opløsning

novartis healthcare a/s - moxifloxacinhydrochlorid - øjendråber, opløsning - 5 mg/ml

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Liên Minh Châu Âu - Tiếng Đan Mạch - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Ciloxan 3 mg/g øjensalve Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

ciloxan 3 mg/g øjensalve

novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit - øjensalve - 3 mg/g

Ciloxan 3 mg/ml øredråber, opløsning Đan Mạch - Tiếng Đan Mạch - Lægemiddelstyrelsen (Danish Medicines Agency)

ciloxan 3 mg/ml øredråber, opløsning

novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit - øredråber, opløsning - 3 mg/ml